Cixutumumab
Product Specifications
CAS Number
947687-12-9
Target
IGF-1R
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.985
Bioactivity
Cixutumumab (IMC-A12) is a humanized IgG monoclonal antibody targeting the insulin-like growth factor 1 receptor (IGF1R) . It has anticancer activity, inhibits ligand-dependent receptor activation and downstream signaling, and can be used in the study of non-small cell lung and prostate cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog